Piribedil

Uses your system voice; voice and rate in settings.

Snapshot

≈ 2 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Piribedil is an antiparkinsonian agent and piperazine derivative which acts as a D 2 and D 3 receptor agonist. It also has α 2 -adrenergic antagonist properties.

Piribedil is an antiparkinsonian agent and piperazine derivative which acts as a D 2 and D 3 receptor agonist. It also has α 2 -adrenergic antagonist properties.

Medical uses

Treatment of Parkinson's disease (PD), either as monotherapy (without levodopa) or in combination with L -DOPA therapy, in the early stages of the disease as well as in the advanced ones Treatment of pathological cognitive deficits in the elderly (impaired attention, motivation, memory, etc.) Treatment of dizziness in the young patients Treatment of retinal ischemic manifestations Adjunctive treatment of intermittent claudication due to peripheral vascular disease (PVD) of the lower limbs (stage 2) Adjunctive treatment of anhedonia, apathy and treatment-resistant depression in unipolar and bipolar depressives (off-label) Treatment of gait disorders associated with Parkinson's disease (no related cause) and other forms of parkinsonism

Other uses

The drug has been shown to enhance working memory capacities in normal aging adults. In age-related memory impairment, it has a positive effect on psychophysiological state of elderly people, improving memory and attention and increasing the velocity of psychomotor reactions and lability of nervous processes. It enhances cognitive skill learning in healthy older adults. It showed a positive effect in restless legs syndrome.

Side effects

Minor gastrointestinal upset (nausea, vomiting, flatulence, etc.) in predisposed individuals, or when taken between meals: adjust dosage individually, and/or add domperidone Orthostatic hypotension or drowsiness may occur, particularly in predisposed individuals (underlying condition or causative illness) Mild dizziness, confusion and feeling "drunk" also may occur As with other dopamine agonists (like pramipexole and ropinirole), compulsive behavior like pathological gambling, overeating, excessive shopping, increased libido, sexual and/or other intense urges, may develop. Another rare side effect of piribedil is excessive daytime sleepiness and unintended sleep episodes.

Overdose

At very high doses, piribedil has an emetic action on the chemoreceptor trigger zone (CTZ). Tablets will thus be rapidly rejected, which explains why no data are currently available concerning the risk of overdosage.

Pharmacology

Pharmacodynamics

Dopamine receptor agonist, selective for subtypes D 2 and D 3 Dopamine receptor antagonist, selective for subtypes D 4 . Adrenergic receptor antagonist, subtypes α 2A and α 2C . Lack of affinity to serotonin receptor 5-HT 2B .

Text derived from https://en.wikipedia.org/w/index.php?oldid=1329150568 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

3 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.